/
/
/

Nath Bio-Genes (India) Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)149.50
Volume (₹)8,860.00
High (₹)151.49
Upper Circuit177.62
Low (₹)148.30
Lower Circuit118.42
Prev Close148.02
52W High (₹)204.00
Price150.80
52W Low (₹)126.15

Share Market Cap & Key Ratios Overview

M.Cap (₹)280.02 Cr
Div. Yield (%)1.36
PE Ratio7.65
Debt to Equity0.20
Price to Book0.36
Book Value358.06
EPS (TTM)19.26
Face Value10.00
ROE (%)6.28

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
KSCLNSE
VENKEYSNSE
AVTNPLNSE
REGAALNSE
FRESHARA-STNSE
BSHSLNSE
MGELNSE
SHEETAL-SMNSE
KOTYARK-BENSE
NATHBIOGENNSE
LTP
1W Low
1W High
Market cap (₹)
783.85+87.5 (12.57%)
694.90
819.95
3,647Cr
1664.1+17.3 (1.05%)
1632
1741.90
2,387Cr
92.93+7.23 (8.44%)
84.41
102
1,476Cr
90.61+6.58 (7.83%)
82.03
103
974Cr
407.85-43.1 (-9.56%)
398
442.05
954Cr
87.6-0.27 (-0.31%)
83.35
89.90
916Cr
15.51-0.13 (-0.83%)
15.30
15.99
508Cr
357.9-1.1 (-0.31%)
340
360
425Cr
31.48+0.31 (0.99%)
30.60
32.89
366Cr
150.8+3.46 (2.35%)
145.02
153.76
280Cr

Key Highlights of Nath Bio-Genes (India) Ltd Balance Sheet

Nath Bio-Genes (India) Ltd balance sheet discloses shareholders' funds of ₹19Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹19Cr, and the reserves and surplus of the company is ₹629.66Cr.

The company has its non-current liabilities with total liabilities of ₹1016.87Cr as of 2025-03-31.

The current liabilities are ₹363.05Cr as of 2025-03-31. At the same time, current assets are ₹680.55Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹6.05Cr and tangible assets of ₹250.22Cr, provided in the Nath Bio-Genes (India) Ltd financial statements.